Literature DB >> 16395558

Interindividual variability in the absorption of ciprofloxacin and hydrocortisone from continent ileal reservoir for urine.

F Mattioli1, P Tognoni, V Manfredi, M Gosmar, C Corbu, C Garbero, A Martelli.   

Abstract

OBJECTIVE: The neobladder created with a detubularized segment of ileum as standard treatment for the transitional cell carcinoma of the bladder may permit absorption of drugs. As a consequence, on the one hand the elimination of drugs excreted in the urine may be delayed and a change of dosage may be required, and on the other hand the intravesical administration of a drug may produce blood levels capable of inducing unwanted systemic effects. The purpose of the present study was to explore the possibility of drug absorption from a continent ileal reservoir for urine.
METHODS: The possibility of drug re-absorption from a continent ileal reservoir for urine was studied in 12 patients with well functioning reservoirs after a time interval of 3 months from surgery and also, in 7 of them, 6 months later. Saline solutions of ciprofloxacin or hydrocortisone were instilled and maintained in the reservoir for 2 h, and drug concentrations in plasma were measured 1 and 2 h after instillation.
RESULTS: Both ciprofloxacin and to a lower extent hydrocortisone were adsorbed from the reservoir, but with large interindividual variability. A comparison of the plasma concentrations produced by the two drugs 3 and 9 months after creation of the new bladder revealed that after 9 months the absorption was decreased in 3 patients, substantially unchanged in 2, and increased in 2.
CONCLUSIONS: The results of this study show that both ciprofloxacin, chosen for its use as possible radiosensitizing agent in bladder cancer patients, and hydrocortisone, chosen as an example of lypofilic endogenous compound, can be absorbed through the intestinal mucosa of a continent ileal reservoir, but to a different extent and with high interindividual variability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395558     DOI: 10.1007/s00228-005-0090-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Lithium toxicity after urinary diversion with ileal conduit.

Authors:  A Alhasso; A A Bryden; D Neilson
Journal:  BMJ       Date:  2000-04-15

Review 2.  Everything you wanted to know about the bladder epithelium but were afraid to ask.

Authors:  S A Lewis
Journal:  Am J Physiol Renal Physiol       Date:  2000-06

3.  Absorption of drugs from continent caecal reservoir for urine.

Authors:  I Ekman; W Månsson; L Nyberg
Journal:  Br J Urol       Date:  1989-10

4.  Simultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenbutazone in equine serum by high-performance liquid chromatography.

Authors:  E Grippa; L Santini; G Castellano; M T Gatto; M G Leone; L Saso
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-01-28

5.  Methotrexate toxicity associated with an ileal conduit.

Authors:  G W Bowyer; T W Davies
Journal:  Br J Urol       Date:  1987-12

6.  Morphologic changes in ileal reservoir mucosa after long-term exposure to urine. A study in patients with continent urostomy (Kock pouch).

Authors:  T Höckenström; N G Kock; L J Norlén; C Ahrén; B M Philipson
Journal:  Scand J Gastroenterol       Date:  1986-12       Impact factor: 2.423

7.  Functional and structural studies of ileal reservoirs used for continent urostomy and ileostomy.

Authors:  B M Philipson; N G Kock; R Jagenburg; C Ahrén; L Norlén; J W Robinson; H Menge
Journal:  Gut       Date:  1983-05       Impact factor: 23.059

8.  Unexpectedly high serum methotrexate levels in cystectomized bladder cancer patients with an ileal conduit treated with intermediate doses of the drug.

Authors:  S D Fosså; A Heilo; O Børmer
Journal:  J Urol       Date:  1990-03       Impact factor: 7.450

  8 in total
  1 in total

1.  Metabolic changes after urinary diversion.

Authors:  Frank Van der Aa; Steven Joniau; Marcel Van Den Branden; Hein Van Poppel
Journal:  Adv Urol       Date:  2011-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.